Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT06761599
Frequency of Pulmonary Toxicity in Patients Treated for Hodgkin Lymphoma
Sponsor: Superior University
View on ClinicalTrials.gov
Summary
Pulmonary toxicity during Hodgkin lymphoma treatment is significant for a variety of reasons, ranging from clinical care to therapeutic innovation and patient outcomes.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
214
Start Date
2024-02-18
Completion Date
2025-03-01
Last Updated
2025-01-07
Healthy Volunteers
Yes
Conditions
Interventions
DIAGNOSTIC_TEST
group 1
To determine treatment-induced pulmonary toxicity prevalence and risk factors in Hodgkin lymphoma patients during chemotherapy or radiation therapy.
Locations (1)
Shaukat Khanum Memorial Cancer Hospital and Research Centre, 5-B, Sector A2, Phase 5, Hayatabad
Peshawar, Khyber Pakhtunkhwa, Pakistan